EQ-5D-5L测量乳房再造生活质量获益的有效性
本研究为10年横断面队列,463例乳房切除患者完成在线调查,其中自体重建202例、假体重建103例、未重建158例。通过与Breast-Q及EORTC问卷比较,评估EQ-5D-5L的心理测量学性能。结果显示EQ-5D-5L能区分有无并发症、有无重建及与一般人群的差异,但无法区分自体重建与假体重建及重建与一般人群,总体支持其作为乳房再造健康经济学评价结局指标的有效性。
要点
- EQ-5D-5L可区分有无并发症及有无乳房再造。
- EQ-5D-5L无法区分自体重建与假体重建。
- EQ-5D-5L与Breast-Q等特异性问卷聚合效度良好。
核心结论
- 研究结果支持EQ-5D-5L作为乳房再造健康经济学评价结局指标的有效性。
研究设计与样本
- 10年横断面队列研究,纳入463例乳房切除患者,其中自体重建202例、假体重建103例、未重建158例。
主要发现
- EQ-5D-5L能区分有无并发症的患者、未重建患者有无重建以及未重建患者与一般人群。
- EQ-5D-5L不能区分自体重建与假体重建,也不能区分重建患者与一般人群。
- EQ-5D-5L及其各维度均显示良好的聚合效度与区分效度。
- EQ-5D-5L与乳房再造特异性生活质量方面(如性生活和身体意象)呈中度相关。
临床怎么用
- 在乳房再造的健康经济学评价中,EQ-5D-5L可作为有效的结局测量工具。
局限性
- 无法区分自体重建与假体重建及重建与一般人群的原因不明,可能为工具不敏感、样本量不足或组间无实际差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The EuroQol EQ-5D-5L instrument is the most widely used quality of life (QoL) measure in health economic evaluations. It is unclear whether such a generic instrument is valid enough to estimate the benefits of breast reconstruction (BR), given the specific changes observed in QoL after BR. Hence, we aimed to evaluate the validity of the EQ-5D-5L in patients who had undergone postmastectomy BR. METHODS: In a 10-year cross-sectional cohort study, 463 mastectomy patients completed an online survey: 202 patients with autologous-BR (A-BR), 103 with implant-based-BR (I-BR), and 158 without BR (MAS). The results were used to evaluate the psychometric performance of the EQ-5D-5L with respect to the ceiling effect and to known-group, convergent, and discriminant validity, by comparing it with the Breast-Q, the cancer-specific (EORTC-QLQ-C30), and breast cancer-specific (EORTC-QLQ-BR23) questionnaires. RESULTS: The EQ-5D-5L was able to discriminate between patients with and without complications, MAS with or without BR and MAS versus the general population. It was, however, not able to discriminate between A-BR vs. I-BR as well as BR vs. general population. It is not clear whether this was due to the insensitivity of the instrument, insufficient sample sizes, or because there were no actual differences in QoL between these groups. Good convergent and discriminant validity of both the EQ-5D-5L and its individual dimensions were demonstrated. Additional support for the instrument's validity was revealed by moderate correlations between the generic EQ-5D-5L and specific QoL aspects of BR such as sexuality and body image. CONCLUSIONS: The results of this study support the validity of the EQ-5D-5L as an outcome measure in health economic evaluations of BR.
引用
- Kouwenberg CAE, Kranenburg LW, Visser MS, et al. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction". J Plast Reconstr Aesthet Surg. 2018. PMID: 30270015. doi:10.1016/j.bjps.2018.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。